Skip to main content

Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese/overweight women with polycystic ovary syndrome

Published Online: Doi: https://doi.org/10.1024/0300-9831/a000588

Abstract.Background: Polycystic ovary syndrome is one of the most important factors in female infertility. Oxidative stress is likely to contribute to increased insulin and androgen production in the ovaries, as well as probably impairing follicle production. Aims: This study aims to determine the complementary effects of omega-3 and vitamin E supplements on certain oxidative stress indices in obese and overweight women with polycystic ovary syndrome. Materials and Methods: This double-blind, randomized clinical trial was performed on polycystic ovary syndrome subjects with BMI > 25. Patients were randomly allocated into two groups to receive either 2 g of omega-3 plus 400 IU of vitamin E, or a placebo, for 8 weeks. At the beginning and the end of the study, total antioxidant capacity, glutathione levels, catalase activity, malondialdehyde concentrations, as well as dietary intake and physical activity were evaluated. Statistical analysis was performed using SPSS. Results: 32 patients in the intervention group and 30 patients in the placebo group completed the study. Co-supplementation of omega-3 and vitamin E significantly increased total antioxidant capacity (mg/dl) (1.15 ± 0.93 vs −0.6 ± 0.72; P < 0.001), catalase activity (IU/L) (1.19 ± 1.06 vs 0.12 ± 0.36; P < 0.001) and glutathione levels (μmol/L) (1.5 ± 1.06 vs 0.23 ± 1.43; P = 0.028). Additionally, a significant reduction of malondialdehyde levels (nmol/L) (−0.34 ± 0.32 vs 0.57 ± 2.20; P = 0.008) was observed, in comparison with placebo. Conclusion: Co-supplementation with omega-3 and vitamin E had beneficial effect on total antioxidant capacity, malondialdehyde concentrations, glutathione levels and catalase activity.

References

  • 1 Inhorn, M.C., & Patrizio, P. (2015) Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 21(4), 411–26. First citation in articleCrossref MedlineGoogle Scholar

  • 2 Nadjarzadeh, A., Firouzabadi, R.D., Vaziri, N., Daneshbodi, H., Lotfi, M.H., & Mozaffari-Khosravi, H. (2013) The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial. Iran J Reprod Med. 11(8), 665. First citation in articleMedlineGoogle Scholar

  • 3 Baptiste, C.G., Battista, M.-C., Trottier, A., & Baillargeon, J.-P. (2010) Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 122(1–3), 42–52. First citation in articleCrossref MedlineGoogle Scholar

  • 4 Plati, E., Kouskouni, E., Malamitsi-Puchner, A., Boutsikou, M., Kaparos, G., & Baka, S. (2010) Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. Fertil Steril. 94(4), 1451–6. First citation in articleCrossref MedlineGoogle Scholar

  • 5 Abbasi, K., Beigrezai, S., Ghiasvand, R., Pourmasoumi, M., & Mahaki, B. (2018) Dietary patterns and attention deficit hyperactivity disorder among Iranian children: A case-control study. J Am Coll Nutr. 1–8. First citation in articleGoogle Scholar

  • 6 Khani, B., Mardanian, F., & Fesharaki, S.J. (2017) Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Res Med Sci. 22. First citation in articleMedlineGoogle Scholar

  • 7 Oner, G., & Muderris, I.I. (2013) Efficacy of omega-3 in the treatment of polycystic ovary syndrome. J Obstet Gynaecol. 33(3), 289–91. First citation in articleCrossref MedlineGoogle Scholar

  • 8 Fr, D.D., & Tarlatzis, R. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 81(1). First citation in articleGoogle Scholar

  • 9 González, F., Rote, N.S., Minium, J., & Kirwan, J.P. (2006) Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 91(1), 336–40. First citation in articleCrossref MedlineGoogle Scholar

  • 10 Mohammadi, E., Rafraf, M., Farzadi, L., Asghari-Jafarabadi, M., & Sabour, S. (2012) Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr. 21(4), 511–8. First citation in articleMedlineGoogle Scholar

  • 11 Sabuncu, T., Vural, H., Harma, M., & Harma, M. (2001) Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 34(5), 407–13. First citation in articleCrossref MedlineGoogle Scholar

  • 12 Heshmati, N., Shahgheibi, S., Nikkhoo, B., Amini, S., & Abdi, M. (2017) Association of prooxidant-antioxidant balance with clinical and laboratory parameters and its relation to different drug regimens in polycystic ovary syndrome women with normal BMI. Indian J Clin Biochem. 32(3), 315–22. First citation in articleCrossref MedlineGoogle Scholar

  • 13 Mohan, S.K., & Priya, V. (2009) Lipid peroxidation, glutathione, ascorbic acid, vitamin E, antioxidant enzyme and serum homocysteine status in patients with polycystic ovary syndrome. BLM. 1(3), 44–9. First citation in articleGoogle Scholar

  • 14 Nadjarzadeh, A., Dehghani-Firouzabadi, R., Daneshbodi, H., Lotfi, M.H., Vaziri, N., & Mozaffari-Khosravi, H. (2015) Effect of Omega-3 supplementation on Visfatin, adiponectin, and anthropometric indices in women with polycystic ovarian syndrome. J Reprod Infertil. 16(4), 212. First citation in articleMedlineGoogle Scholar

  • 15 Mehrabian, F., Khani, B., Kelishadi, R., & Ghanbari, E. (2011) The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol. 62(3), 238–42. First citation in articleMedlineGoogle Scholar

  • 16 Pourmasoumi, M., Vosoughi, N., Derakhshandeh-Rishehri, S.-M., Assarroudi, M., & Heidari-Beni, M. (2018) Association of omega-3 fatty acid and epileptic seizure in epileptic patients: A systematic review. Int J Prev Med. 9(1), 36. First citation in articleCrossref MedlineGoogle Scholar

  • 17 Ebrahimi, F.A., Samimi, M., Foroozanfard, F., Jamilian, M., Akbari, H., Rahmani, E., et al. (2017) The effects of Omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind, Placebo-Controlled Trial. Exp Clin Endocrinol Diabetes. 125(06), 353–9. First citation in articleCrossref MedlineGoogle Scholar

  • 18 Pasquali, R., Stener-Victorin, E., Yildiz, B.O., Duleba, A.J., Hoeger, K., Mason, H., et al. (2011) PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol. 74(4), 424–33. First citation in articleCrossref MedlineGoogle Scholar

  • 19 Azziz, R. (2006) Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 91(3), 781–5. First citation in articleCrossref MedlineGoogle Scholar

  • 20 Benzie, I.F., & Strain, J.J. (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 239(1), 70–6. First citation in articleCrossref MedlineGoogle Scholar

  • 21 Rajaei, Z., Hadjzadeh, M.-A.-R., Nemati, H., Hosseini, M., Ahmadi, M., & Shafiee, S. (2013) Antihyperglycemic and antioxidant activity of crocin in streptozotocin-induced diabetic rats. J Med Food. 16(3), 206–10. First citation in articleCrossref MedlineGoogle Scholar

  • 22 Aebi, H. (1984) [13] Catalase in vitro. In Methods Enzymol (vol. 105, pp. 121–6). Elsevier. First citation in articleCrossrefGoogle Scholar

  • 23 CMd, Costa., dos Santos, R.C., & Lima, E.S. (2006) A simple automated procedure for thiol measurement in human serum samples. J Bras Patol Med Lab. 42(5), 345–50. First citation in articleGoogle Scholar

  • 24 Verit, F.F., Erel, O., & Kocyigit, A. (2007) Association of increased total antioxidant capacity and anovulation in nonobese infertile patients with clomiphene citrate–resistant polycystic ovary syndrome. Fertil Steril. 88(2), 418–24. First citation in articleCrossref MedlineGoogle Scholar

  • 25 Zhang, J., Zhang, Y., Liu, H., Bai, H., Wang, Y., Jiang, C., et al. (2015) Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome. Fertil Steril. 103(5), 1346–54. First citation in articleCrossref MedlineGoogle Scholar

  • 26 Mori, T.A., & Beilin, L.J. (2004) Omega-3 fatty acids and inflammation. Curr Atheroscler Rep. 6(6), 461–7. First citation in articleCrossref MedlineGoogle Scholar

  • 27 Romieu, I., Garcia-Esteban, R., Sunyer, J., Rios, C., Alcaraz-Zubeldia, M., Velasco, S.R., et al. (2008) The effect of supplementation with omega-3 polyunsaturated fatty acids on markers of oxidative stress in elderly exposed to PM2. 5. Environ Health Perspect. 116(9), 1237. First citation in articleCrossref MedlineGoogle Scholar

  • 28 Tayyebi-Khosroshahi, H., Houshyar, J., Tabrizi, A., Vatankhah, A.-M., Zonouz, N.R., & Dehghan-Hesari, R. (2010) Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis. Iran J Kidney Dis. 4(4), 322. First citation in articleMedlineGoogle Scholar

  • 29 Harper, C.R., & Jacobson, T.A. (2001) The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med. 161(18), 2185–92. First citation in articleCrossref MedlineGoogle Scholar

  • 30 Murri, M., Luque-Ramirez, M., Insenser, M., Ojeda-Ojeda, M., & Escobar-Morreale, H.F. (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 19(3), 268–88. First citation in articleCrossref MedlineGoogle Scholar

  • 31 Sarbolouki, S., Djalali, M., Dorosty, A., Djazayery, S., Eshraghian, M., Ebadi, S., et al. (2010) Effects of EPA and vitamin E on serum enzymatic antioxidants and peroxidation indices in patients with type II Diabetes mellitus. Iran J Public Health. 39(3), 82–91. First citation in articleMedlineGoogle Scholar

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.